ZVIA trades 104.7% below Wall Street's consensus target of $3.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ZVIA achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Zevia PBC (ZVIA) has a Wall Street consensus price target of $3.50, based on estimates from 8 covering analysts. With the stock currently trading at $1.71, this represents a potential upside of +104.7%. The company has a market capitalization of $115M.
Analyst price targets range from a low of $3.00 to a high of $4.00, representing a 29% spread in expectations. The median target of $3.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ZVIA trades at a trailing P/E of -11.4x. Analysts expect EPS to grow -29.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CELHCelsius Holdings, Inc. | $8.1B | $31.70 | $49.57 | +56.4% | Buy | 19.6x | 23 |
FIZZNational Beverage Corp. | $3.0B | $32.48 | $33.00 | +1.6% | Sell | 16.2x | 8 |
NRGVEnergy Vault Holdings, Inc. | $656M | $3.79 | $7.00 | +84.7% | Buy | — | 7 |
KOThe Coca-Cola Company | $361.8B | $84.05 | $86.50 | +2.9% | Buy | 25.7x | 48 |
PEPPepsiCo, Inc. | $198.2B | $144.98 | $167.20 | +15.3% | Hold | 16.8x | 45 |
MNSTMonster Beverage Corporation | $94.8B | $96.92 | $90.58 | -6.5% | Buy | 42.2x | 44 |
KDPKeurig Dr Pepper Inc. | $42.8B | $31.49 | $33.40 | +6.1% | Buy | 13.8x | 28 |
SAMThe Boston Beer Company, Inc. | $2.0B | $183.16 | $242.25 | +32.3% | Hold | 19.2x | 31 |
SYYSysco Corporation | $40.0B | $83.53 | $90.44 | +8.3% | Buy | 18.2x | 30 |
UNFIUnited Natural Foods, Inc. | $2.9B | $47.25 | $46.60 | -1.4% | Hold | 18.6x | 43 |
Quick answers to the most common questions about buying ZVIA stock.
The consensus Wall Street price target for ZVIA is $3.5, representing 104.7% upside from the current price of $1.71. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ZVIA has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $3.5 implies 104.7% upside from current levels.
ZVIA's current price is $1.71 with a consensus target of $3.5 (104.7% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $4 for ZVIA, while the most conservative target is $3. The consensus of $3.5 represents the median expectation. These targets typically reflect 12-month expectations.
ZVIA is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ZVIA stock forecast based on 8 Wall Street analysts shows a consensus price target of $3.5, with estimates ranging from $3 (bear case) to $4 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on ZVIA, with a "Buy" consensus rating and $3.5 price target (104.7% upside). 4 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ZVIA analyst price targets range from $3 to $4, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $3.5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.